Ubidecarenone and Zometa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ubidecarenone (coenzyme q - 10) and Zometa (zoledronic acid). Common drug interactions include neutropenia among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Ubidecarenone and Zometa. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Ubidecarenone?

Ubidecarenone has active ingredients of coenzyme q - 10. eHealthMe is studying from 3,373 Ubidecarenone users. Check the latest studies of Ubidecarenone.

What is Zometa?

Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.



On Jul, 06, 2026

47 people who take Ubidecarenone and Zometa together, and have interactions are studied.

Ubidecarenone and Zometa drug interactions.

What are the common drug interactions of Ubidecarenone and Zometa, by gender? *:

female:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Tumour marker increased
  3. Nausea (feeling of having an urge to vomit)
  4. Anxiety
  5. Cough
  6. Dyspnoea (difficult or laboured respiration)
  7. Myalgia (muscle pain)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Pain in extremity
  10. Rash

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Decreased appetite
  4. Limb injury
  5. Oedema (fluid collection in tissue)
  6. Peripheral swelling
  7. Rash
  8. Urinary tract infection
  9. Affective disorder (mental disorder)
  10. Agitation (state of anxiety or nervous excitement)

What are the common drug interactions of Ubidecarenone and Zometa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arthralgia (joint pain)
  2. Cough
  3. Dyspnoea (difficult or laboured respiration)
  4. Myalgia (muscle pain)
  5. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in extremity
  8. Rash
  9. Visual impairment
  10. Abdominal distension

60+:

  1. Diarrhoea
  2. Muscle spasms (muscle contraction)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Hypotension (abnormally low blood pressure)
  6. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  7. Myalgia (muscle pain)
  8. Neuropathy peripheral (surface nerve damage)
  9. Pain
  10. Pain in jaw

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 13 people, 27.66%
  2. Pain: 7 people, 14.89%
  3. Nausea (feeling of having an urge to vomit): 7 people, 14.89%
  4. Constipation: 7 people, 14.89%
  5. Breast Cancer: 5 people, 10.64%
  6. Metastases To Bone (cancer spreads to bone): 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Ubidecarenone and Zometa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ubidecarenone and Zometa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ubidecarenone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zometa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ubidecarenone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zometa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 and zoledronic acid (the active ingredients of Ubidecarenone and Zometa, respectively), and Ubidecarenone and Zometa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: